EMSP at EMA’s Working Party for Patients and Consumers: Clinical trials, benefit-risk evaluation, interaction guidance


EMSP was represented at the 3 June meeting of the Patients’ and Consumers’ Working Party (PCWP) established by the European Medicines Agency (EMA).

EMSP’s External Affairs Director Christoph Thalheim outlined the three focus areas of the meeting:

  • PCWP’s involvement summarising clinical trial results for laypersons.
  • Patient involvement in benefit-risk evaluation
  • Interaction guidance in the framework of the European Patients’ Academy on Therapeutic Innovation (EUPATI)

Christoph Thalheim made a special mention about the clinical trial results for laypersons, saying that once published they will be very important for EMSP members because they aim for a more patient-oriented language.

The meeting agenda can be found here.

More information on PCWP can be found here.

Related Articles